Article Detail - JE Part A
Self-Administered Drug Exclusion List (A53032) - R39 - Effective September 11, 2024
Date Posted: September 26, 2024
This coverage article has been revised and published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).
Effective Date: September 11, 2024
Summary of Changes:
EXCLUDED CPT/HCPCS CODES:
Removed: Asterisk (*) from J3590, J3490, and C9399 secukinumab (Cosentyx) subcutaneous use. This is effective 07/01/2024.
Added: Asterisk (*) to J1628 guselkumab (Tremfya®)*. This is effective 09/11/2024.
09/26/2024: At this time, 21st Century Cures Act applies to new and revised LCDs which require comment and notice. This revision is to an article that is not a local coverage determination.
Visit the Self-Administered Drugs (SADs) webpage to view the Self-Administered Drug Exclusion List.
To view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Billing and Coding Articles webpage.
